{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T17:18:17Z","timestamp":1787937497161,"version":"build-2784847793"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":52,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Diabetic kidney disease (DKD) is the leading cause of kidney failure worldwide. While sodium-glucose co-transporter 2 inhibitors (SGLT2i) confer remarkable renoprotection, the molecular mechanisms underlying their efficacy remain incompletely understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed an integrative cross-species transcriptomic analysis comparing dapagliflozin-modulated signatures in diabetic mice with human DKD pathophysiology. Public RNA-sequencing datasets were analyzed: GSE142025 (human kidney biopsies: advanced DKD n = 21, early DKD n = 6, controls n = 9) and GSE228727 (diabetic db\/db mice \u00b1 dapagliflozin).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Advanced human DKD exhibited 2145 dysregulated genes (False Discovery Rate [FDR] &amp;lt; 0.05) enriched in fibrosis and inflammation pathways. In contrast, dapagliflozin induced a focused 13-gene signature (11 downregulated, 2 upregulated). Matched-cohort analysis revealed minimal overlap between drug and disease signatures: only 7 dapagliflozin-downregulated genes were among diabetes-upregulated genes (hypergeometric P = .542). Gene Set Enrichment Analysis confirmed no global transcriptional reversal (normalized enrichment score [NES] = \u22121.04, FDR q = 0.86). Despite this limited overlap, unsupervised clustering using the 13-gene signature robustly stratified human patients by disease state.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>SGLT2 inhibitors do not reverse disease transcriptional programs but operate through indirect modulation of a focused gene signature largely independent of primary disease drivers. This signature provides prioritized candidates for mechanistic investigation and biomarker development in DKD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/joneph\/aajag074","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T12:56:26Z","timestamp":1773838586000},"page":"1012-1020","source":"Crossref","is-referenced-by-count":0,"title":["Dapagliflozin modulates diabetic kidney disease through indirect transcriptional regulation rather than direct transcriptional reversal"],"prefix":"10.1093","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2882-4226","authenticated-orcid":false,"given":"Francesco","family":"Pesce","sequence":"first","affiliation":[{"name":"Department of Translational Medicine and Surgery, Universit\u00e0 Cattolica del Sacro Cuore , Rome 00168 ,","place":["Italy"]},{"name":"Division of Renal Medicine, Ospedale Isola Tiberina\u2014Gemelli Isola , Rome 00186 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8527-5594","authenticated-orcid":false,"given":"Camillo Tancredi","family":"Strizzi","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine and Surgery, Universit\u00e0 Cattolica del Sacro Cuore , Rome 00168 ,","place":["Italy"]},{"name":"Nephrology, Dialysis and Transplantation Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS , Rome 00168 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Granata","sequence":"additional","affiliation":[{"name":"Nephrology and Dialysis Unit, \u201cCannizzaro\u201d Emergency Hospital , Catania 95126 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Elena","family":"Bracaccia","sequence":"additional","affiliation":[{"name":"Division of Renal Medicine, Ospedale Isola Tiberina\u2014Gemelli Isola , Rome 00186 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Muzi","sequence":"additional","affiliation":[{"name":"Division of Renal Medicine, Ospedale Isola Tiberina\u2014Gemelli Isola , Rome 00186 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7564-2724","authenticated-orcid":false,"given":"Vassilios","family":"Liakopoulos","sequence":"additional","affiliation":[{"name":"Section of Nephrology and Hypertension, 1st Department of Medicine, AHEPA Hospital, Aristotle University of Thessaloniki , Thessaloniki 546 21 ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Grandaliano","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine and Surgery, Universit\u00e0 Cattolica del Sacro Cuore , Rome 00168 ,","place":["Italy"]},{"name":"Nephrology, Dialysis and Transplantation Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS , Rome 00168 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"key":"2026082812321118700_aajag074-B1","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1053\/j.ackd.2017.10.011","article-title":"The global epidemiology of diabetes and kidney disease","volume":"25","author":"Koye","year":"2018","journal-title":"Adv Chronic Kidney Dis"},{"key":"2026082812321118700_aajag074-B2","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.2215\/CJN.11491116","article-title":"Diabetic kidney disease: challenges, progress, and possibilities","volume":"12","author":"Alicic","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026082812321118700_aajag074-B3","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1172\/JCI72271","article-title":"Molecular mechanisms of diabetic kidney disease","volume":"124","author":"Reidy","year":"2014","journal-title":"J Clin Invest"},{"key":"2026082812321118700_aajag074-B4","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41581-019-0234-4","article-title":"Innate immunity in diabetic kidney disease","volume":"16","author":"Tang","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"2026082812321118700_aajag074-B5","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N Engl J Med"},{"key":"2026082812321118700_aajag074-B6","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1056\/NEJMoa2204233","article-title":"Empagliflozin in patients with chronic kidney disease","volume":"387","author":"The EMPA-KIDNEY Collaborative Group","year":"2022","journal-title":"N Engl J Med"},{"key":"2026082812321118700_aajag074-B7","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N Engl J Med"},{"key":"2026082812321118700_aajag074-B8","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/s41581-020-0256-y","article-title":"The tubular hypothesis of nephron filtration and diabetic kidney disease","volume":"16","author":"Vallon","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"2026082812321118700_aajag074-B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2021.02.016","article-title":"A kidney perspective on the mechanism of action of sodium glucose co-transporter 2 inhibitors","author":"Sen","year":"2021","journal-title":"Cell Metab"},{"key":"2026082812321118700_aajag074-B10","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.2337\/db19-0204","article-title":"Comparison of kidney transcriptomic profiles of early and advanced diabetic nephropathy reveals potential new mechanisms for disease progression","volume":"68","author":"Fan","year":"2019","journal-title":"Diabetes"},{"key":"2026082812321118700_aajag074-B11","doi-asserted-by":"publisher","first-page":"155621","DOI":"10.1089\/ars.2022.0169","article-title":"Dapagliflozin alleviates diabetic kidney disease via HIF1\u03b1\/HO1 mediated ferroptosis","volume":"146","author":"Wang","year":"2023","journal-title":"Metabolism"},{"key":"2026082812321118700_aajag074-B12","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"2026082812321118700_aajag074-B13","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1093\/bioinformatics\/btp358","article-title":"BioMart and bioconductor: a powerful link between annotation and experimental data","volume":"25","author":"Durinck","year":"2009","journal-title":"Bioinformatics"},{"key":"2026082812321118700_aajag074-B14","doi-asserted-by":"publisher","first-page":"btac757","DOI":"10.1093\/bioinformatics\/btac757","article-title":"GSEApy: a comprehensive package for performing gene set enrichment analysis in python","volume":"39","author":"Fang","year":"2023","journal-title":"Bioinformatics"},{"key":"2026082812321118700_aajag074-B15","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s11658-024-00647-w","article-title":"The nuclear receptor NR4A1 is a novel endogenous inhibitor of the c-GAS-STING pathway","volume":"7","author":"Wang","year":"2021","journal-title":"Cell Discov"},{"key":"2026082812321118700_aajag074-B16","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s11658-024-00647-w","article-title":"Research progress of ankyrin repeat domain 1 protein: an updated review","volume":"29","author":"Xu","year":"2024","journal-title":"Cell Mol Biol Lett"},{"key":"2026082812321118700_aajag074-B17","doi-asserted-by":"publisher","first-page":"11772","DOI":"10.1074\/jbc.M109336200","article-title":"Interaction of CED-6\/GULP, an adapter protein involved in engulfment of apoptotic cells with CED-1 and CD91\/low density lipoprotein receptor-related protein (LRP)","volume":"277","author":"Su","year":"2002","journal-title":"J Biol Chem"},{"key":"2026082812321118700_aajag074-B18","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1016\/j.ekir.2024.02.1435","article-title":"Narrative review of immunomodulatory and anti-inflammatory effects of sodium-glucose cotransporter 2 inhibitors: unveiling novel therapeutic frontiers","volume":"9","author":"Lee","year":"2024","journal-title":"Kidney Int Rep"},{"key":"2026082812321118700_aajag074-B19","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1016\/j.febslet.2007.06.025","article-title":"Human SFMBT is a transcriptional repressor protein that selectively binds the N-terminal tail of histone H3","volume":"581","author":"Wu","year":"2007","journal-title":"FEBS Lett"},{"key":"2026082812321118700_aajag074-B20","doi-asserted-by":"publisher","first-page":"6238","DOI":"10.1074\/jbc.M112.429605","article-title":"Proteomic and functional analyses reveal the role of chromatin reader SFMBT1 in regulating epigenetic silencing and the myogenic gene program","volume":"288","author":"Lin","year":"2013","journal-title":"J Biol Chem"},{"key":"2026082812321118700_aajag074-B21","doi-asserted-by":"publisher","first-page":"774","DOI":"10.4049\/jimmunol.1103067","article-title":"Ecto-nucleoside triphosphate diphosphohydrolase 7 controls Th17 cell responses through regulation of luminal ATP in the small intestine","volume":"190","author":"Kusu","year":"2013","journal-title":"J Immunol"},{"key":"2026082812321118700_aajag074-B22","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.kint.2016.08.029","article-title":"Purinergic signaling in kidney disease","volume":"91","author":"Menzies","year":"2017","journal-title":"Kidney Int"},{"key":"2026082812321118700_aajag074-B23","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3389\/fendo.2018.00423","article-title":"Increased circulation and adipose tissue levels of DNAJC27\/RBJ in obesity and type 2-diabetes","volume":"9","author":"Cherian","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026082812321118700_aajag074-B24","doi-asserted-by":"publisher","first-page":"F1054","DOI":"10.1152\/ajprenal.00021.2011","article-title":"The endoplasmic reticulum stress response and diabetic kidney disease","volume":"300","author":"Cunard","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"2026082812321118700_aajag074-B25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41581-024-00919-w","article-title":"Mitochondrial dysfunction has a central role in diabetic kidney disease","volume":"21","author":"Li","year":"2025","journal-title":"Nat Rev Nephrol"},{"key":"2026082812321118700_aajag074-B26","doi-asserted-by":"publisher","first-page":"pgae568","DOI":"10.1093\/pnasnexus\/pgae568","article-title":"ZHX3 interacts with CEBPB to repress hepatic gluconeogenic gene expression and uric acid secretion","volume":"4","author":"Tan","year":"2025","journal-title":"PNAS Nexus"},{"key":"2026082812321118700_aajag074-B27","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nrm2309","article-title":"Smc5\/6: a link between DNA repair and unidirectional replication?","volume":"9","author":"Murray","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2026082812321118700_aajag074-B28","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.cmet.2022.05.010","article-title":"Mapping the single-cell transcriptomic response of murine diabetic kidney disease to therapies","volume":"34","author":"Wu","year":"2022","journal-title":"Cell Metab"},{"key":"2026082812321118700_aajag074-B29","doi-asserted-by":"publisher","first-page":"101334","DOI":"10.1016\/j.xcrm.2023.101334","article-title":"Dapagliflozin protects against chronic heart failure in mice by inhibiting macrophage-mediated inflammation, independent of SGLT2","volume":"4","author":"Wu","year":"2023","journal-title":"Cell Rep Med"},{"key":"2026082812321118700_aajag074-B30","doi-asserted-by":"publisher","first-page":"F68","DOI":"10.1152\/ajprenal.00231.2024","article-title":"Transcriptomics of SGLT2-positive early proximal tubule segments in mice: response to type 1 diabetes, SGLT1\/2 inhibition, or GLP1 receptor agonism","volume":"328","author":"Kim","year":"2025","journal-title":"Am J Physiol Renal Physiol"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/joneph\/article-pdf\/39\/5\/1012\/69855375\/aajag074.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/joneph\/article-pdf\/39\/5\/1012\/69855375\/aajag074.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T16:32:16Z","timestamp":1787934736000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/39\/5\/1012\/8740352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":30,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,8,28]]},"published-print":{"date-parts":[[2026,8,28]]}},"URL":"https:\/\/doi.org\/10.1093\/joneph\/aajag074","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2026,6]]}}}